Skip to content

Corneal Incisions With the IntraLase iFS Femtosecond Laser System

A MULTI-CENTER PROSPECTIVE STUDY TO EVALUATE THE USE OF THE INTRALASE iFS™ FEMTOSECOND LASER SYSTEM TO CREATE CLEAR CORNEAL INCISIONS AND PARACENTESIS INCISIONS FOR CATARACT SURGERY

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01713660
Enrollment
37
Registered
2012-10-25
Start date
2012-11-30
Completion date
2013-01-31
Last updated
2025-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract

Keywords

Cataract surgery, Femtosecond laser, Corneal incisions

Brief summary

The IntraLase iFS femtosecond laser system can create corneal arcuate incisions for cataract surgery.

Interventions

DEVICEiFS Femtosecond Laser

corneal incisions created by the femtosecond laser

Sponsors

Abbott Medical Optics
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* At least 21 years of age * Unilateral or bilateral cataract(s) for which phacoemulsification lens extraction and posterior chamber intraocular lens (IOL) implantation has been planned * Visual potential of 20/25 or better in each study eye following cataract removal and IOL implantation * Clear intraocular media other than cataract * Available, willing and capable of complying with examination procedures and follow-up visits for the duration of the study * Signed informed consent

Exclusion criteria

* Previous intraocular or corneal surgery, including refractive surgery in the operative eye(s) * History of active or recurrent ophthalmic disease * Abnormal topography, including evidence of keratoconus or pellucid marginal degeneration or irregular astigmatism in the operative eye(s) * White to white measurement less than 10 mm or greater than 14 mm * Corneal pathology/abnormality that may interfere with the transmission of laser energy, laser light or precludes applanation * Corneal pathology/abnormality that is predicted to cause visual acuity losses to a level of 20/30 (Snellen) or worse during the study * Subjects with diagnosed degenerative visual disorders (e.g., macular or other retinal pathology) that are predicted to cause visual acuity losses to a level of 20/30 (Snellen) or worse during the study * Subjects with conditions associated with increased risk of IOL/capsule instability * Pharmacologically dilated pupil size less than 5.5 mm or the presence of any pupil abnormalities * Prior, current, or anticipated use during the course of the study of tamsulosin, silodosin or pilocarpine (e.g. Flomax, Flomaxtra, Rapaflo) * History of any ocular or medical conditions that could affect corneal wound healing * Poorly-controlled diabetes or subjects with diabetic retinopathy * Concurrent use of topical or systemic medications that may impair corneal wound healing * Acute, chronic, or uncontrolled systemic or ocular disease or illness that would, in the opinion of the investigator, increase the operative risk or confound the outcome(s) of the study (e.g., immunocompromised, connective tissue disease, etc.) * Ocular hypertension (\> 21 mm Hg) * Women who are pregnant, breast-feeding, or intend to become pregnant over the course of the study * Known sensitivity or inappropriate responsiveness to any of the medications used in the post operative course * Concurrent participation or participation in any other clinical trial during the duration of this clinical study including 30 days prior to preoperative visit

Design outcomes

Primary

MeasureTime frameDescription
Demonstration That the Femtosecond Laser Consistently Produces Desired Incisions.Day 0, Operative (Within 2 hours of incision creation)Evaluation of incisions created as programmed and measurement in mm. Data reported will be based on intended incision size (as programmed) vs. achieved incision size (as measured).

Secondary

MeasureTime frameDescription
Surgeon Assessment of WorkflowDay 0, OperativeSurgeon questionnaire (completed at the end of each surgery and the end of each surgical day): Were incisions created as intended?
Percent of Seidel StainingDay 0 (performed immediately post-incision creation), Day 1Demonstration of no wound leakage as measured by Seidel test at slit lamp with fluorscein dye. A negative Seidel test result indicates no wound leakage.

Participant flow

Recruitment details

Subjects were recruited from private medical practices from October to December 2012

Pre-assignment details

No preassignment details

Participants by arm

ArmCount
FS Corneal Incisions
iFS Femtosecond Laser : corneal incisions created by the femtosecond laser
37
Total37

Baseline characteristics

CharacteristicFS Corneal Incisions
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
22 Participants
Age, Categorical
Between 18 and 65 years
15 Participants
Age, Continuous66 years
STANDARD_DEVIATION 6
Region of Enrollment
United States
37 participants
Sex: Female, Male
Female
15 Participants
Sex: Female, Male
Male
22 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 37
serious
Total, serious adverse events
0 / 37

Outcome results

Primary

Demonstration That the Femtosecond Laser Consistently Produces Desired Incisions.

Evaluation of incisions created as programmed and measurement in mm. Data reported will be based on intended incision size (as programmed) vs. achieved incision size (as measured).

Time frame: Day 0, Operative (Within 2 hours of incision creation)

ArmMeasureGroupValue (MEAN)Dispersion
FS Corneal IncisionsDemonstration That the Femtosecond Laser Consistently Produces Desired Incisions.Achieved Clear Corneal Incision (CCI) Measurement2.75 mmStandard Deviation 0.09
FS Corneal IncisionsDemonstration That the Femtosecond Laser Consistently Produces Desired Incisions.Intended CCI Incision Size (as programmed)2.74 mmStandard Deviation 0.08
Secondary

Percent of Seidel Staining

Demonstration of no wound leakage as measured by Seidel test at slit lamp with fluorscein dye. A negative Seidel test result indicates no wound leakage.

Time frame: Day 0 (performed immediately post-incision creation), Day 1

ArmMeasureValue (NUMBER)
FS Corneal IncisionsPercent of Seidel Staining100 percentage of eyes with negative Seidel
Secondary

Surgeon Assessment of Workflow

Surgeon questionnaire (completed at the end of each surgery and the end of each surgical day): Were incisions created as intended?

Time frame: Day 0, Operative

ArmMeasureValue (NUMBER)
FS Corneal IncisionsSurgeon Assessment of Workflow97.3 percentage of yes answers

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026